Antisedative
Alzane 5 mg/mL injectable solution for cats and dogs
Antisedative to reverse the sedative effects of medetomidine and dexmedetomidine
The information available on this page complies with the legislation and texts in vigour in Spain. For all other countries, please refer to the specific local information or contact our Export Department for more information.
*The content of this page is purely informative. For a correct use of the products, please refer to the indications in the Summary of product characteristics..
Quick product information
| Active ingredient(s) | Posology* | Waiting time | Packaging |
|---|---|---|---|
Atipamezole hydrochloride | Intra-muscular | Not applicable | 10 mL vial |
Country Availability
Albania, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Iran, Ireland, Italy, Kazakhstan, Latvia, Lithuania, Luxembourg, Macedonia, Mexico, Netherlands, Norway, Poland, Portugal, Romania, Russia, Slovakia, Slovenia, Sweden.
If your country is not listed, please contact our export team.
Active ingredient(s)
Each mL contains:
Atipamezole hydrochloride………………………………………….5,0 mg (equivalent to 4.27 mg base atipamezole)
Methyl parahydroxybenzoate (E 218)…………………………1 mg
Indications
Atipamezole hydrochloride is a selective α-2 agonist used to reverse the sedative effects of medetomidine and dexmedetomidine in cats and dogs.
Contra-indications
Do not use in animals with known hypersensitivity to the active substance or any of the excipients.
Do not use in breeding animals or those with liver, renal injuries or cardiopathies.
Special precautions
After administration, animals must rest in a quiet place. During resuscitation animals must not be left alone.
Make sure the animal has recovered the swallowing reflex before offering any food or drink.
Due to the different recommended doses, care must be taken if the veterinary medication is administered in species different to those it is aimed at.
Atipamezole does not reverse the effect of ketamine, which may cause convulsions in dogs and cause cramps in cats when used alone. Do not use atipamezole between 30 and 40 minutes after administration of ketamine.
In humans: avoid any contact with the skin, eyes and mucous membranes. In the event of accidental spillage on the skin or eyes, wash the area affected immediately with clean running water. Remove contaminated clothing in direct contact with the skin. Go to the doctor if the irritation persists. Avoid self-injection or accidental ingestion. In the event of self-injection or accidental consumption, go to a doctor immediately and show them the package insert. DO NOT DRIVE.
Posology
Dogs:
5 times the dose (as μg per kg of weight) of medetomidine hydrochloride or 10 times the dose of dexmedetomidine hydrochloride. Equivalent to the same administered volume of medetomidine hydrochloride of 1 mg/mL or the same administered volume of dexmedetomidine hydrochloride of 0,5 mg/mL. Equivalent to 1/5 the administered volume of dexmedetomidine hydrochloride 0.1 mg/mL.
Cats:
2.5 times the dose (as μg per kg of weight) of medetomidine hydrochloride or 5 times the dose of dexmedetomidine hydrochloride. Equivalent to 1/2 the administered volume of medetomidine hydrochloride 1 mg/mL or 1/2 the administered volume of dexmedetomidine 0.5 mg/mL. Equivalent to 1/10 the administered volume of dexmedetomidine hydrochloride 0.1 mg/mL.
Waiting time
Not applicable
Packaging
Box with 1 x 10 ml vials
With veterinary prescription
Registry no.: 2151 ESP
